Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Asset Utilization Ratio (2018 - 2025)

Historic Asset Utilization Ratio for Autolus Therapeutics (AUTL) over the last 8 years, with Q3 2025 value amounting to 0.07.

  • Autolus Therapeutics' Asset Utilization Ratio rose 51536.67% to 0.07 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07, marking a year-over-year increase of 51536.67%. This contributed to the annual value of 0.02 for FY2024, which is 34549.14% up from last year.
  • Autolus Therapeutics' Asset Utilization Ratio amounted to 0.07 in Q3 2025, which was up 51536.67% from 0.04 recorded in Q2 2025.
  • In the past 5 years, Autolus Therapeutics' Asset Utilization Ratio ranged from a high of 0.07 in Q3 2025 and a low of 0.0 during Q1 2022
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.01 (2024), whereas its average is 0.01.
  • As far as peak fluctuations go, Autolus Therapeutics' Asset Utilization Ratio crashed by 9009.18% in 2022, and later soared by 346606.71% in 2023.
  • Quarter analysis of 5 years shows Autolus Therapeutics' Asset Utilization Ratio stood at 0.0 in 2021, then surged by 2042.23% to 0.02 in 2022, then plummeted by 73.55% to 0.0 in 2023, then soared by 189.51% to 0.01 in 2024, then soared by 487.73% to 0.07 in 2025.
  • Its Asset Utilization Ratio was 0.07 in Q3 2025, compared to 0.04 in Q2 2025 and 0.01 in Q1 2025.